Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurochem Res ; 33(7): 1316-24, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18270818

RESUMO

Polyvalent cations and hypertonic shrinking of presynaptic endings lead to calcium-independent exocytosis in various synapses. In the present study we have investigated the contribution of integrins to this phenomenon. It was found that hypertonic shrinking, polyvalent cations ruthenium red and gadolinium results in dose-dependent calcium-independent neurotransmitter release in rat brain synaptosomes. The exocytotic mechanism of neurotransmitter release induced by 300 microM gadolinium was additionally verified by the fluorescent dye FM2-10. We found that 200 microM of RGDS peptide, an inhibitor of integrins, decreased polyvalent gadolinium-induced [3H]D: -aspartate release by 26%. This compound had no effect upon hypertonicity-induced release. The peptide RGES, a negative control for RGDS; genistein, an inhibitor of tyrosine kinases; and citrate, an inhibitor of lanthanides-induced aggregation were ineffective in both cases. Therefore, we have shown that integrins did not influence hypertonicity-evoked [3H]D: -aspartate release, but partially mediated that evoked by gadolinium ions.


Assuntos
Gadolínio/farmacologia , Soluções Hipertônicas/farmacologia , Integrinas/antagonistas & inibidores , Neurotransmissores/metabolismo , Oligopeptídeos/farmacologia , Sinaptossomos/metabolismo , Animais , Ácido Aspártico/metabolismo , Química Encefálica/efeitos dos fármacos , Cátions/farmacologia , Relação Dose-Resposta a Droga , Exocitose/efeitos dos fármacos , Corantes Fluorescentes , Proteínas do Tecido Nervoso/metabolismo , Compostos de Piridínio , Compostos de Amônio Quaternário , Ratos , Ratos Wistar , Sacarose/farmacologia , Sinaptossomos/efeitos dos fármacos , Ácido gama-Aminobutírico/metabolismo
2.
Brain Res Bull ; 73(1-3): 135-42, 2007 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-17499647

RESUMO

Neurotransmitter release is dependent on both calcium and sodium influx. Hypotonic swelling and hypertonic shrinking of neurons evokes calcium-independent exocytosis of neurotransmitters into the synaptic cleft. To date, there are not too much data available on relationship between extracellular osmolarity and sodium concentration in presynaptic endings. In the present study we investigated the effects of hypotonic swelling and hypertonic shrinking on sodium levels, as measured using fluorescent dyes SBFI-AM and Sodium Green in rat brain synaptosomes. Reduction of incubation medium osmolarity from 310 to 230 mOsm did not raise the intrasynaptosomal sodium concentration. An increase of osmolarity from 310 to 810 mOsm is accompanied by a dose-dependent elevation of sodium concentration from 8.1+/-0.5 to 46.5+/-2.8mM, respectively. This effect was insensitive to several channel inhibitors such as: tetrodotoxin, an inhibitor of voltage-gated sodium channels, bumetanide, an inhibitor of Na(+)/K(+)/2Cl(-) cotransport, gadolinium, an inhibitor of nonselective mechanosensitive channels, ruthenium red, an inhibitor of transient receptor potential channel and amiloride, an inhibitor of epithelial sodium channel/degenerin. Additionally, using the fluorescent dye BCECF-AM, we have shown that hypertonic shrinking caused a dose-dependent acidification of intrasynaptosomal cytosol, which suggests that the Na(+)/H(+) exchanger is not involved in the effect of increased osmolarity on cytosolic sodium levels. The increase in intrasynaptosomal sodium concentrations following increases in osmolarity is probably due to sodium influx through another sodium channels.


Assuntos
Química Encefálica/efeitos dos fármacos , Soluções Hipertônicas/farmacologia , Soluções Hipotônicas/farmacologia , Sódio/metabolismo , Sinaptossomos/efeitos dos fármacos , Sinaptossomos/ultraestrutura , Amilorida/farmacologia , Animais , Benzofuranos , Bumetanida/farmacologia , Diuréticos/farmacologia , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Canais Iônicos/efeitos dos fármacos , Canais Iônicos/metabolismo , Masculino , Compostos Orgânicos , Concentração Osmolar , Ácidos Ftálicos , Ratos , Ratos Wistar , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/metabolismo , Sacarose/farmacologia , Sinaptossomos/metabolismo , Tetrodotoxina/farmacologia
3.
Neurosci Lett ; 405(1-2): 106-10, 2006 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-16835010

RESUMO

It is well established that calcium-dependent neurotransmitter release and exocytosis can be regulated by altering the cholesterol content of the plasma membrane. We have compared the influence of cholesterol depletion of synaptosomal plasma membrane by 15 mM methyl-beta-cyclodextrin (MCD) treatment on calcium-dependent release of D-[(3)H]aspartate induced by the calcium ionophore A23187 and on calcium-independent release induced by hypertonic shrinking or polyvalent cations. We found that decrease of cholesterol concentration by 9.3% inhibited calcium-dependent release of d-[(3)H]aspartate induced by calcium ionophore A23187 by four times while release induced by 300 microM Gd(3+), 150 mM and 500 mM sucrose remained unchanged. Further we have investigated the influence of MCD on exocytosis monitored by the fluorescent dye, acridine orange. Cholesterol depletion inhibited calcium-dependent exocytosis induced by calcium ionophore A23187 but had virtually no influence on calcium-independent exocytosis induced by hypertonic shrinking or Gd(3+). In summary, we found that the cholesterol content in synaptosomal plasma membrane is important for calcium-dependent exocytosis.


Assuntos
Encéfalo/metabolismo , Cálcio/fisiologia , Colesterol/metabolismo , Exocitose , Sinaptossomos/metabolismo , Laranja de Acridina , Animais , Ácido Aspártico/metabolismo , Calcimicina/farmacologia , Membrana Celular/metabolismo , Corantes Fluorescentes , Gadolínio/farmacologia , Soluções Hipertônicas/farmacologia , Técnicas In Vitro , Ionóforos/farmacologia , Masculino , Ratos , Ratos Wistar , beta-Ciclodextrinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...